Post by Deleted on Mar 5, 2015 10:28:25 GMT -6
How about some good news, for a change?
Now this sounds very promising. The article goes on with more detail....
Source
I doesn't appear to do anything for the more aggressive and vicious small-cell form, but as the end of the article notes there? The form it does seem to have an impact with is the most common, among the leading cause of cancer related death.
Progress!
(Reuters) - U.S. health regulators on Wednesday swiftly approved a Bristol-Myers Squibb Co drug that helps the immune system fight the most common form of lung cancer, sending the company's shares up more than 5 percent to a multi-year high.
Now this sounds very promising. The article goes on with more detail....
Opdivo, known chemically as nivolumab, was approved to treat non-small cell lung cancer after the disease has progressed following platinum-based chemotherapy, typically the first-line treatment against the disease. It was previously approved to treat advanced melanoma, the deadliest form of skin cancer.
Opdivo belongs to a highly promising new class of medicines called PD-1 inhibitors that work by blocking a mechanism tumors use to hide from the immune system, allowing it to recognize and attack cancer cells.
Opdivo belongs to a highly promising new class of medicines called PD-1 inhibitors that work by blocking a mechanism tumors use to hide from the immune system, allowing it to recognize and attack cancer cells.
I doesn't appear to do anything for the more aggressive and vicious small-cell form, but as the end of the article notes there? The form it does seem to have an impact with is the most common, among the leading cause of cancer related death.
Progress!
